2020
DOI: 10.3390/biomedicines8120578
|View full text |Cite
|
Sign up to set email alerts
|

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, in Contrast to Adipose Tissue-Derived Stromal Cells, Efficiently Improve Heart Function in Murine Model of Myocardial Infarction

Abstract: Cell therapies are extensively tested to restore heart function after myocardial infarction (MI). Survival of any cell type after intracardiac administration, however, may be limited due to unfavorable conditions of damaged tissue. Therefore, the aim of this study was to evaluate the therapeutic effect of adipose-derived stromal cells (ADSCs) and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) overexpressing either the proangiogenic SDF-1α or anti-inflammatory heme oxygenase-1 (HO-1) in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 35 publications
0
20
0
Order By: Relevance
“…All hiPSCs lines in this study were generated with the use of Sendai vectors (CytoTune-iPS Sendai Reprogramming Kit, ThermoFisher Scientific, Waltham, MA, USA). Control hiPSCs (HPSI1013ikuxp_1 line) from male skin fibroblasts were obtained from The Human Induced Pluripotent Stem Cells Initiative’s collection ( , accessed on 9 January 2017) or were generated from peripheral blood mononuclear cells (PBMCs) isolated from a healthy volunteer as described by Stępniewski et al [ 30 ]. The DMD hiPSCs line was reprogrammed from fibroblasts derived from a DMD patient carrying a mutation in gene encoding dystrophin (deletion of DMD exon 45) purchased from the Coriell Institute for Medical Research.…”
Section: Methodsmentioning
confidence: 99%
“…All hiPSCs lines in this study were generated with the use of Sendai vectors (CytoTune-iPS Sendai Reprogramming Kit, ThermoFisher Scientific, Waltham, MA, USA). Control hiPSCs (HPSI1013ikuxp_1 line) from male skin fibroblasts were obtained from The Human Induced Pluripotent Stem Cells Initiative’s collection ( , accessed on 9 January 2017) or were generated from peripheral blood mononuclear cells (PBMCs) isolated from a healthy volunteer as described by Stępniewski et al [ 30 ]. The DMD hiPSCs line was reprogrammed from fibroblasts derived from a DMD patient carrying a mutation in gene encoding dystrophin (deletion of DMD exon 45) purchased from the Coriell Institute for Medical Research.…”
Section: Methodsmentioning
confidence: 99%
“…We added 10 µM ROCK inhibitor Y-27632 (Abcam, Cambridge, United Kingdom) to the culture medium for the first 24 h after passage. Differentiation towards cardiomyocytes was performed according to the published protocol [62,63]. Briefly, hiPSCs were seeded in Geltrex TM -coated 24-well plates and cultured in E8 until reaching 90% confluency.…”
Section: Differentiation Of Human Ipsc-derived Cardiomyocytesmentioning
confidence: 99%
“…Several literatures provide abundant information that human adipocytes mesenchymal stem cells (h-AMSCs) is an attractive resource for therapeutics and have beneficial effects in regenerating injured cardiomyocytes due to their self-renewal ability and broad differentiation potential under physiological and pathological conditions. [1][2][3] Despite the impressive potential of the h-AMSC-based therapy, several obstacles (e.g., the difficulty of maintaining self-renewal and poor survival due to apoptosis and/or necrosis at the administration site) have been encountered. 4 Some studies suggest that more than 90% of transplanted stem cells, either intravenously, intramyocardially, and intracoronary delivery, have necrosis and apoptosis and only about 5% transplanted stem cells can survive up to 14 days in infarcted myocardium.…”
Section: Introductionmentioning
confidence: 99%
“…Several literatures provide abundant information that human adipocytes mesenchymal stem cells (h-AMSCs) is an attractive resource for therapeutics and have beneficial effects in regenerating injured cardiomyocytes due to their self-renewal ability and broad differentiation potential under physiological and pathological conditions. 13…”
Section: Introductionmentioning
confidence: 99%